43 related articles for article (PubMed ID: 9425256)
1. Low extracellular pH induces activation of ERK 2, JNK, and p38 in A431 and Swiss 3T3 cells.
Xue L; Lucocq JM
Biochem Biophys Res Commun; 1997 Dec; 241(2):236-42. PubMed ID: 9425256
[TBL] [Abstract][Full Text] [Related]
2. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
3. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
[TBL] [Abstract][Full Text] [Related]
5. Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos.
Mirkes PE; Wilson KL; Cornel LM
Teratology; 2000 Jul; 62(1):14-25. PubMed ID: 10861629
[TBL] [Abstract][Full Text] [Related]
6. Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells.
Mitsui H; Maruyama T; Kimura S; Takuwa Y
Hepatology; 1998 May; 27(5):1362-7. PubMed ID: 9581692
[TBL] [Abstract][Full Text] [Related]
7. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production.
Cooper KL; Myers TA; Rosenberg M; Chavez M; Hudson LG
Toxicol Appl Pharmacol; 2004 Nov; 200(3):177-85. PubMed ID: 15504454
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
9. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor.
Popik W; Pitha PM
Virology; 1998 Dec; 252(1):210-7. PubMed ID: 9875330
[TBL] [Abstract][Full Text] [Related]
10. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways.
Jun CD; Oh CD; Kwak HJ; Pae HO; Yoo JC; Choi BM; Chun JS; Park RK; Chung HT
J Immunol; 1999 Mar; 162(6):3395-401. PubMed ID: 10092794
[TBL] [Abstract][Full Text] [Related]
12. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.
Nagata Y; Takahashi N; Davis RJ; Todokoro K
Blood; 1998 Sep; 92(6):1859-69. PubMed ID: 9731042
[TBL] [Abstract][Full Text] [Related]
13. ERK2 signalling from internalised epidermal growth factor receptor in broken A431 cells.
Xue L; Lucocq J
Cell Signal; 1998 May; 10(5):339-48. PubMed ID: 9692677
[TBL] [Abstract][Full Text] [Related]
14. Thrombin induces activation of p38 MAP kinase in human platelets.
Kramer RM; Roberts EF; Strifler BA; Johnstone EM
J Biol Chem; 1995 Nov; 270(46):27395-8. PubMed ID: 7499191
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a novel MAP kinase kinase kinase, MLTK.
Gotoh I; Adachi M; Nishida E
J Biol Chem; 2001 Feb; 276(6):4276-86. PubMed ID: 11042189
[TBL] [Abstract][Full Text] [Related]
16. Stress-activated protein kinases: activation, regulation and function.
Paul A; Wilson S; Belham CM; Robinson CJ; Scott PH; Gould GW; Plevin R
Cell Signal; 1997 Sep; 9(6):403-10. PubMed ID: 9376221
[TBL] [Abstract][Full Text] [Related]
17. Signaling events controlling the molecular response to genotoxic stress.
Holbrook NJ; Liu Y; Fornace AJ
EXS; 1996; 77():273-88. PubMed ID: 8856980
[TBL] [Abstract][Full Text] [Related]
18. ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain binding.
Ang BK; Lim CY; Koh SS; Sivakumar N; Taib S; Lim KB; Ahmed S; Rajagopal G; Ong SH
J Mol Signal; 2007 Feb; 2():1. PubMed ID: 17284314
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction.
Kiso-Farnè K; Tsuruyama T
Sci Rep; 2022 Oct; 12(1):16950. PubMed ID: 36216834
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the cytotoxicity of Ge-Sb-Se chalcogenide glass optical fibres on 3T3 mouse fibroblasts.
Mabwa D; Kubiena T; Parnell H; Su R; Furniss D; Tang Z; Leach R; Benson TM; Scotchford CA; Seddon AB
RSC Adv; 2021 Feb; 11(15):8682-8693. PubMed ID: 35423389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
